Subcutaneous emphysema, pneumothorax and pneumomediastinum are well-known complications of invasive ventilation in patients with acute hypoxemic respiratory failure. We determined the incidences of air leaks that were visible on available chest images in a cohort of critically ill patients with acute hypoxemic respiratory failure due to coronavirus disease of 2019 (COVID-19) in a single-center cohort in the Netherlands. A total of 712 chest images from 154 patients were re-evaluated by a multidisciplinary team of independent assessors; there was a median of three (2–5) chest radiographs and a median of one (1–2) chest CT scans per patient. The incidences of subcutaneous emphysema, pneumothoraxes and pneumomediastinum present in 13 patients (8.4%) were 4.5%, 4.5%, and 3.9%. The median first day of the presence of an air leak was 18 (2–21) days after arrival in the ICU and 18 (9–22)days after the start of invasive ventilation. We conclude that the incidence of air leaks was high in this cohort of COVID-19 patients, but it was fairly comparable with what was previously reported in patients with acute hypoxemic respiratory failure in the pre-COVID-19 era.
Forensisch sociale professionals komen regelmatig in aanraking met cliënten bij wie zich een of meerdere ingrijpende ervaringen in hun leven hebben voorgedaan. Het begeleiden van deze cliënten kan uitdagend zijn omdat het verband tussen ingrijpende ervaringen uit het verleden en klachten in het heden regelmatig gemist wordt. Trauma wordt beschreven als een directe risicofactor voor gewelddadig gedrag en indirecte risicofactor door middel van mediërende variabelen zoals impulsiviteit, negatieve emotionaliteit of hypervigilantie en achterdocht. Trauma kan ook gezien worden als responsiviteitsfactor omdat traumagerelateerde symptomen de behandeling en het toezicht bemoeilijken. Deze symptomen kunnen er voor zorgen dat cliënten hun programma niet kunnen volgen, niet op afspraken kunnen verschijnen of niet optimaal kunnen profiteren van de therapie. In dit hoofdstuk wordt het verband tussen ingrijpende ervaringen uit het verleden en klachten in het heden nader beschreven en concrete adviezen geformuleerd hoe hier in de praktijk zo goed mogelijk mee om te gaan.
BackgroundHyperbaric oxygen therapy (HBOT) is used to treat various wound types. However, the possible beneficial and harmful effects of HBOT for acute wounds are unclear.MethodsWe undertook a systematic review to evaluate the effectiveness of HBOT compared to other interventions on wound healing and adverse effects in patients with acute wounds. To detect all available randomized controlled trials (RCTs) we searched five relevant databases up to March 2010. Trial selection, quality assessment, data extraction, and data synthesis were conducted by two of the authors independently.ResultsWe included five trials, totaling 360 patients. These trials, with some methodologic flaws, included different kinds of wound and focused on different outcome parameters, which prohibited meta-analysis. A French trial (n = 36 patients) reported that significantly more crush wounds healed with HBOT than with sham HBOT [relative risk (RR) 1.70, 95% confidence interval (CI) 1.11–2.61]. Moreover, there were significantly fewer additional surgical procedures required with HBOT (RR 1.60, 95% CI 1.03–2.50), and there was significantly less tissue necrosis (RR 1.70, 95% CI 1.11–2.61). In one of two American trials (n = 141) burn wounds healed significantly quicker with HBOT (P < 0.005) than with routine burn care. A British trial (n = 48) compared HBOT with usual care. HBOT resulted in a significantly higher percentage of healthy graft area in split skin grafts (RR 3.50, 95% CI 1.35–9.11). In a Chinese trial (n = 145) HBOT did not significantly improve flap survival in patients with limb skin defects.ConclusionsHBOT, if readily available, appears effective for the management of acute, difficult to heal wounds.
